| Janet Woodcock, acting commissioner of the Food and Drug Administration, said in a tweet that she is asking the Office of Inspector General in the Department of Health and Human Services to examine the FDA's dealings with Biogen, the manufacturer of the recently approved drug Aduhelm. The approval set off a firestorm, with critics saying the medication doesn't work and accusing the agency of getting too close to the company, but in a letter requesting the investigation, Woodcock said she has "tremendous confidence in the integrity" of the staff and leadership of the FDA involved in the approval. | 
No comments:
Post a Comment